Matches in Nanopublications for { ?s ?p "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP486707.RA3wz9dyMjO5E7eZM2fhLAr1PwNDXPcG5wCFeDWFQ72Xk130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486707.RA3wz9dyMjO5E7eZM2fhLAr1PwNDXPcG5wCFeDWFQ72Xk130_provenance.
- NP561958.RAijbRarOcCHI-utyya7PP1KngvlIy5ymfo-LTgQusSaE130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561958.RAijbRarOcCHI-utyya7PP1KngvlIy5ymfo-LTgQusSaE130_provenance.
- assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP761799.RAKj9Mh-8hp52s3mnFzxNyw4ZKN0S31APiQr63T8DmGlw130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761799.RAKj9Mh-8hp52s3mnFzxNyw4ZKN0S31APiQr63T8DmGlw130_provenance.
- NP1053324.RAZHLp0LBIel0sixqEUOI-P7O8jU_5aC9kpOynrRkuso4130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053324.RAZHLp0LBIel0sixqEUOI-P7O8jU_5aC9kpOynrRkuso4130_provenance.
- NP1053325.RAXjcdlXqo4Jh_sI6M1NKeE-Yc-5pq8IksXlao0IAQc-Q130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053325.RAXjcdlXqo4Jh_sI6M1NKeE-Yc-5pq8IksXlao0IAQc-Q130_provenance.
- NP341803.RAnUCBIK61Ykd3FsBuLQKXu09uvmO0unki_jrKRnCD2Do130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341803.RAnUCBIK61Ykd3FsBuLQKXu09uvmO0unki_jrKRnCD2Do130_provenance.
- NP1053326.RAsXQpf5TRf59p-F9tjwe3Uy6RyeI9HeoxHT7dM7Z1Qzg130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053326.RAsXQpf5TRf59p-F9tjwe3Uy6RyeI9HeoxHT7dM7Z1Qzg130_provenance.
- NP341840.RA_81DhpqBhoIZWw8umvdWViFrbJnxm-vgBKxeesOqDPk130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341840.RA_81DhpqBhoIZWw8umvdWViFrbJnxm-vgBKxeesOqDPk130_provenance.
- NP341847.RA8EGOItB2opnnGvXfxYjYxTMZv4OlNVtuy2jXddArQ70130_assertion description "[CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341847.RA8EGOItB2opnnGvXfxYjYxTMZv4OlNVtuy2jXddArQ70130_provenance.